Directed differentiation
Induced pluripotent stem cells provide the starting point for developing defined cartilage cell populations. Our research focuses on cell identity, consistency and control of unwanted differentiation.
/
iPSC SCIENCE. CARTILAGE REGENERATION.
A new wave in regenerative medicine.
We are developing iPSC-derived cell therapies to advance cartilage repair and help restore movement.
Explore our scienceQbiopharmaConceptual scientific illustration01 / SCIENCE
Qbiopharma / 启澜生物
Built around the biology of repair.
Qbiopharma brings together stem cell science, tissue engineering and clinical insight. Our initial focus is an off-the-shelf cartilage repair approach designed to work within familiar orthopaedic procedures.
OUR SCIENCE
From a renewable cell source to functional tissue.
AI-informed process development
We integrate cellular imaging and biological readouts to prioritise experimental conditions and refine differentiation processes.
Mechanical maturation
Controlled mechanical environments help us study cartilage maturation, extracellular matrix formation and tissue function.
RESEARCH FOCUS
Cartilage first. A platform for regeneration.
Our lead research programme explores iPSC-derived cartilage cells and organoids as an adjunct to microfracture surgery for focal cartilage defects.
Initial indication
Focal knee cartilage defects
Product concept
Off-the-shelf cartilage cells and organoids
Development focus
Preclinical evidence and process development
Investigational research. No product approval or clinical benefit is claimed. Safety and effectiveness require further evaluation.
ABOUT Qbiopharma
Science with a clinical perspective.
Qbiopharma (启澜生物) focuses on regenerative medicine and cell therapy. We connect laboratory research with the practical demands of surgical delivery, manufacturing and quality control.
01Defined cell identity
02Reproducible manufacturing
03Evidence-led translation
Qbiopharma